期刊文献+

血浆极长链脂肪酸GC-MS测定方法的建立和应用 被引量:9

Establishment of GC-MS method for the determination of plasma very long fatty acid and clinical application
下载PDF
导出
摘要 目的通过建立血浆极长链脂肪酸(VLCFAs)气相色谱-质谱(GC-MS)方法,确立实验室血浆VLCFAs正常参比值,为以脑白质营养不良为表现的过氧化酶体病研究提供检测手段。方法对血浆中VLCFAs进行提取、酯化,并应用GC-MS检测,用选择离子扫描进行定量。检测47例正常人血浆VLCFAs和60例经临床和影像学(脑CT或MRI)初步诊断为脑白质营养不良者,并对9例X_连锁肾上腺脑白质营养不良(X_ALD)中的6例进行头颅氢质子磁共振波谱检测。结果正常对照组血浆C22∶0、C24∶0、C26∶0分别为(32.20±9.39)μmol/L、(24.82±7.20)μmol/L和(0.51±0.13)μmol/L;C24∶0/C22∶0和C26∶0/C22∶0分别为0.883±0.277和0.017±0.006。60例脑白质营养不良患者中有9例血浆C22∶0下降,C24∶0、C26∶0、C24∶0/C22∶0和C26∶0/C22∶0均明显高于正常对照组,结合影像学检查可确诊为X_ALD。结论应用GC-MS法检测血浆VLCFAs的方法,灵敏度、准确性均得到提高,且用血量较少,稳定性好,能为临床诊断提供重要的生化依据。影像学检查和血浆VLCFAs测定相结合是诊断X_ALD的可靠方法。 Objective To establish the normal reference range of plasma very long chain fatty acids (VLCFAs) with gas chromatography-mass spectrometry(GC- MS) and provide chemical diagnostic evidence for inherited disorders of peroxisome. Methods VLCFAs were extracted from blood samples and esterifled. Quantitative analysis was performed using selected ion scan on GC-MS. Sixty patients diagnosed as leukoencephalopathy by brain CT or MRI and 47 normal controls involved in our study. 6 of 9 patients with X-link adrenoleukodystrophy(X-ALD) were examined with 1^H-magnetic resonance spectrum(1^HMRS) . Resuits Plasma C22 : 0, C24 : 0, C26 : 0 values in normal group were (32.20±9.39)mol/L, (24.82±7.20)mol/ L and (0.51 ± 0.13) mol/L respectively, and the ratios of C24 : 0/C22 : 0 and C26 : 0/C22 : 0 were 0.883± 0.277,0. O17±0. 006, respectively. C22:0 decreased and C24: 0, C26 : 0,C24 : 0/C22 : 0, C26 : 0/C22:0 increased significantly in 9 confirmed X-ALD patients. Conclusions Determination of plasma very long fatty acid using GC-MS is stable,reliable and helpful for the chemical diagnosis of leukoencephalopathy.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2005年第8期519-522,共4页 Journal of Clinical Pediatrics
基金 卫生部临床重点学科项目 "十五"国家科技攻关计划项目(编号:2004BA720A01) 973计划项目(编号:2005CB522507)
关键词 气相色谱-质谱 极长链脂肪酸 肾上腺脑白质营养不良 氢质子磁共振波谱 gas chromatography-mass spectrometry very long chain fatty acid X-link adrenoleukodystrophy 1^H-magnetic resonance spectrum
  • 相关文献

参考文献9

二级参考文献21

  • 1隗和明.极长链脂肪酸的检测对过氧化小体病的意义[J].中华神经精神科杂志,1993,26(3):166-169. 被引量:3
  • 2Moser AB, Moser HW. The prenatal diagnosis of X - linked adrenoleukodystrophy. Prenatal Diag, 1999, 19(1): 46-48.
  • 3Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesisandtherapy. Brain, 1997, 120(8): 1485-1508.
  • 4Lachtermacher MBR, Seuanez HN, Moser AB, et al. Determination of 30 X- linked adrenoleukodystrophy mutations, inckuding 15 not previously described. Hum. Mutat, 2000, 15(3): 348-353.
  • 5Maier EM, Roscher AA, Kammeress, et al. Prenatal diagnosis of Xlinked adrenoleukodystrophy combining biochemical. immunocytochemical and DNA analyses. Prenatal Diagn, 1999, 19(4): 364 - 368.
  • 6Restuccia D, Di Lazzaro V, Valeriani M. et al. Neurophysiologic follow- up of long - term dietary? treatment in adult - onset adrenoleukodystrophy. Neurology, 1999: 52(4):810-816.
  • 7Malm G, Ringden O, Anvret M, et al. Treatment of adrenoleukodystrophy with bone marrow transplantation. Acta Paediat, 1997, 86(5):484-492.
  • 8Pai GS, Khan M, Barbosa E, et al. Lovastatin therapy for adrenoleukodystrophy and adrenomyeoneuroparthy: clinal and biochemical observaions on 12 patients. Mol Genet Metab, 2000, 69(4): 312- 322.
  • 9Kemp S, Wei HM, Lu JF. Gene redundancy and pharmucological gene theraphy implications for X - linked adrenoleukodystrophy. Nat Med,1998, 4(7): 1246- 1268.
  • 10Bezman L, Moser HW. Incidence of X - linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet, 1998,76(5): 415-419.

共引文献17

同被引文献64

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部